273 related articles for article (PubMed ID: 16757972)
41. The activity of hematopoietic stem cell transplantation in Korea.
Lee JW; Kim CC
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S92-S95. PubMed ID: 18724315
[TBL] [Abstract][Full Text] [Related]
42. The EBMT activity survey 2008: impact of team size, team density and new trends.
Gratwohl A; Baldomero H; Schwendener A; Gratwohl M; Apperley J; Frauendorfer K; Niederwieser D
Bone Marrow Transplant; 2011 Feb; 46(2):174-91. PubMed ID: 20348970
[TBL] [Abstract][Full Text] [Related]
43. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.
Passweg JR; Baldomero H; Bader P; Bonini C; Cesaro S; Dreger P; Duarte RF; Dufour C; Kuball J; Farge-Bancel D; Gennery A; Kröger N; Lanza F; Nagler A; Sureda A; Mohty M
Bone Marrow Transplant; 2016 Jun; 51(6):786-92. PubMed ID: 26901709
[TBL] [Abstract][Full Text] [Related]
44. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
45. Hematopoietic SCT activity in Asia: a report from the Asia-Pacific Blood and Marrow Transplantation Group.
Yoshimi A; Suzuki R; Atsuta Y; Iida M; Lu DP; Tong W; Ghavamzadeh A; Alimoghaddam K; Lie AK; Liang R; Chan LL; Haipeng L; Tan PL; Hwang WY; Chiou TJ; Chen PM; Van Binh T; Minh NN; Min CK; Hwang TJ; Kodera Y;
Bone Marrow Transplant; 2010 Dec; 45(12):1682-91. PubMed ID: 20190847
[TBL] [Abstract][Full Text] [Related]
46. Hematopoietic stem cell transplants after reduced intensity conditioning regimen (RI-HSCT): report of a workshop of the European group for Blood and Marrow Transplantation (EBMT).
Bacigalupo A
Bone Marrow Transplant; 2000 Apr; 25(8):803-5. PubMed ID: 10808199
[TBL] [Abstract][Full Text] [Related]
47. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2008-2009: report on behalf of the Eastern Mediterranean Bone Marrow Transplantation (EMBMT) Group.
Mohamed SY; Fadhil I; Hamladji RM; Hamidieh AA; Fahmy O; Ladeb S; Alimoghaddam K; Elhaddad A; Nacer RA; Alsharif F; Rasheed W; Jahani M; Mousavi SA; Alseraihy A; Abdel-Rahman F; Al Jefri A; Hussein AA; Alabdulaaly A; Ibrahim A; Bekadja MA; Abboud M; Ahmed P; Dennison D; Bakr M; Benchekroun S; Hussain F; Othman TB; Aljurf M; Ghavamzadeh A
Hematol Oncol Stem Cell Ther; 2011; 4(2):81-93. PubMed ID: 21727769
[TBL] [Abstract][Full Text] [Related]
48. Why are there regional differences in stem cell transplantation activity? An EBMT analysis.
Gratwohl A; Baldomero H; Frauendorfer K; Niederwieser D; ;
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S7-S10. PubMed ID: 18724308
[TBL] [Abstract][Full Text] [Related]
49. Hematopoietic stem cell transplantation activity in Europe.
Gratwohl A; Baldomero H; Passweg J
Curr Opin Hematol; 2013 Nov; 20(6):485-93. PubMed ID: 24104408
[TBL] [Abstract][Full Text] [Related]
50. The role of the EBMT activity survey in the management of hematopoietic stem cell transplantation. European Group for Blood Marrow Treansplantation.
Gratwohl A
Int J Hematol; 2002 Aug; 76 Suppl 1():386-92. PubMed ID: 12430888
[TBL] [Abstract][Full Text] [Related]
51. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
52. The national marrow donor program 20 years of unrelated donor hematopoietic cell transplantation.
Ballen KK; King RJ; Chitphakdithai P; Bolan CD; Agura E; Hartzman RJ; Kernan NA
Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):2-7. PubMed ID: 18721774
[TBL] [Abstract][Full Text] [Related]
53. Early renal injury after myeloablative allogeneic and autologous hematopoietic cell transplantation.
Caliskan Y; Besisik SK; Sargin D; Ecder T
Bone Marrow Transplant; 2006 Jul; 38(2):141-7. PubMed ID: 16770317
[TBL] [Abstract][Full Text] [Related]
54. Trends of hematopoietic stem cell transplantation in the third millennium.
Gratwohl A; Baldomero H
Curr Opin Hematol; 2009 Nov; 16(6):420-6. PubMed ID: 19680124
[TBL] [Abstract][Full Text] [Related]
55. Time-course and risk factors of hypothyroidism following allogeneic hematopoietic stem cell transplantation (HSCT) in children conditioned with fractionated total body irradiation.
Bailey HK; Kappy MS; Giller RH; Gralla J
Pediatr Blood Cancer; 2008 Sep; 51(3):405-9. PubMed ID: 18523993
[TBL] [Abstract][Full Text] [Related]
56. Results of genoidentical hemopoietic stem cell transplantation with reduced intensity conditioning for acute myelocytic leukemia: higher doses of stem cells infused benefit patients receiving transplants in second remission or beyond--the Acute Leukemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation.
Gorin NC; Labopin M; Boiron JM; Theorin N; Littlewood T; Slavin S; Greinix H; Cahn JY; Alessandrino EP; Rambaldi A; Nagler A; Polge E; Rocha V;
J Clin Oncol; 2006 Aug; 24(24):3959-66. PubMed ID: 16880451
[TBL] [Abstract][Full Text] [Related]
57. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
58. [Clinical significance of autologous transplantation with hematopoietic stem cells in leukemia and solid tumors].
Hinterberger W; Adler V; Bauer K; Haberhauer G; Habertheuer KH; Höniger S; Huber K; Kier P; Kittel E; Ruckser R
Wien Med Wochenschr; 1995; 145(2-3):34-40. PubMed ID: 7762250
[TBL] [Abstract][Full Text] [Related]
59. Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients.
Heining C; Spyridonidis A; Bernhardt E; Schulte-Mönting J; Behringer D; Grüllich C; Jakob A; Bertz H; Finke J
Bone Marrow Transplant; 2007 May; 39(10):613-22. PubMed ID: 17384658
[TBL] [Abstract][Full Text] [Related]
60. Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation.
Sanz MA; Labopin M; Gorin NC; de la Rubia J; Arcese W; Meloni G; Bacigalupo A; Alessandrino P; Carreras E; Iriondo A; Novitzky N; Jacobs P; Bandini G; Lo-Coco F; Frassoni F; Rocha V;
Bone Marrow Transplant; 2007 Apr; 39(8):461-9. PubMed ID: 17322930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
